U.S. FDA approves CorMedix's antimicrobial drug

CorMedix

15/11/2023 15:08

Nov 15 (Reuters) - The U.S. Food and Drug Administration
(FDA) on Wednesday approved CorMedix's  CRMD.O  antimicrobial
drug that aims to reduce catheter-related bloodstream infections
(CRBSIs) in patients with kidney disease, the regulator said.

 (Reporting by Christy Santhosh in Bengaluru; Editing by
Shailesh Kuber)
 ((Christy.Santhosh@thomsonreuters.com;))